2016
DOI: 10.1080/21505594.2016.1255399
|View full text |Cite
|
Sign up to set email alerts
|

Superantigens of a superbug: Major culprits ofStaphylococcus aureusdisease?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 27 publications
(31 reference statements)
0
15
0
1
Order By: Relevance
“…The structure-function relationship of several SAgs has been resolved in the past 25 years [6,[38][39][40][41][42][43][44]. On that basis, inactivating mutations have been predicted and experimentally confirmed for a number of staphylococcal SAgs [45][46][47]. The development of detoxified SEB and TSST-1 mutants is most advanced [48,49].…”
Section: Vaccination Against Sagsmentioning
confidence: 99%
See 2 more Smart Citations
“…The structure-function relationship of several SAgs has been resolved in the past 25 years [6,[38][39][40][41][42][43][44]. On that basis, inactivating mutations have been predicted and experimentally confirmed for a number of staphylococcal SAgs [45][46][47]. The development of detoxified SEB and TSST-1 mutants is most advanced [48,49].…”
Section: Vaccination Against Sagsmentioning
confidence: 99%
“…Therefore, an effective SAg toxoid vaccine would elicit both neutralizing anti-SAg antibodies and protective SAg-specific T cell responses. Antibodies are required to neutralize the toxicity of SAgs and dampen the inflammatory response early on during an infection while allowing Th17 cells to take action and clear the infection [47]. Moreover, any SAg toxoid vaccines should be adjuvanted and/or administered in a way that induces a protective Th1/Th17 response while preventing unwanted Th2/Treg responses.…”
Section: Vaccination Against Sagsmentioning
confidence: 99%
See 1 more Smart Citation
“…This has the potential to blunt an observed effect, and, recently, transgenic mice have been developed with humanized, superantigen-responsive HLA molecules to better recapitulate the human host environment [ 124 ]. Despite these challenges, antibodies to superantigens are capable of neutralizing these toxins in several in vivo models and have been associated with protection [ 125 ]. A monoclonal antibody to SEB, 20B1, was shown to be effective against MRSA infection in multiple murine models, including sepsis, skin, and deep-tissue abscess models [ 126 ].…”
Section: Role Of S Aureus Toxins In Human Disementioning
confidence: 99%
“…El Staphylococcus aureus es capaz de secretar entre 23 a 24 superantígenos diferentes serológicamente dentro de los que se encuentran más de 20 enterotoxinas estafi lococcicas (SEs del inglés) entre estas la TSST-1, las SEs con serotipos A, B n , C n , (N=múltiples variantes) D, E, F y G; y la SE -1 (serotipo H, I y J a la X). En función de muchos de estos superantígenos, especialmente el SEA, y con menos frecuencia el SEG, SEC, SEI, se ha explicado la patogénesis de los S.aureus y su evolución hacia la sepsis; así como la patogénesis de los S.aureus meticilina resistentes (MRSA en inglés) asociados a sepsis letal, endocarditis infecciosa y lesión renal en modelos animales debido específi camente a sus superantígenos SEA y SEC, así como al gen mecA que codifi ca la proteína de unión a la penicilina alterada (PBP2a) que es su principal mecanismo de resistencia a la meticilina lo que les hace unos de los microorganismos que más centran la atención en los últimos años de la comunidad científi ca y médica al ser responsables del aumento de la tasas de morbilidad y mortalidad de infecciones por estafi lococos a nivel hospitalario y comunitario dada la multirresistencia que exhiben y el estar asociados (19)(20)(21)(22)(23)(24)(25)(26)(27).…”
Section: Bacterias Gram Positivas: Estructura Molecular Antigénicaunclassified